Evidence map›Paper›PMID 39026694›Full record

ArticlebioRxiv : the preprint server for biology2025

An in vivo screen for proteolytic switch domains that can mediate Notch activation by force.

Frederick C Baker, Jacob Harman, Trevor Jordan, Breana Walton, Amber Ajamu-Johnson, Rama F Alashqar, Simran Bhikot, Gary Struhl, Paul D Langridge

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Frederick C Baker
Jacob Harman
Trevor Jordan
Breana Walton
Amber Ajamu-Johnson
Rama F Alashqar
Simran Bhikot
Gary Struhl
Paul D Langridge

Funding

Morphogen control of organ growth in DrosophilaR35GM127141 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gary Struhl · 2018 to 2026
$6.2M
NIGMS NIH HHS R35 GM127141
6 · The paper itself

Abstract

Notch proteins are single pass transmembrane receptors activated by sequential extracellular and intramembrane cleavages that release their cytosolic domains to function as transcription factors in the nucleus. Upon binding, Delta/Serrate/LAG-2 (DSL) ligands activate Notch by exerting a "pulling" force across the intercellular ligand/receptor bridge. This pulling force is generated by Epsin-mediated endocytosis of ligand into the signal-sending cell, and results in the extracellular cleavage of the force-sensing Negative Regulatory Region (NRR) of the receptor by an ADAM10 protease [Kuzbanian (Kuz) in One sentence summary: A scalable in vivo screen for Epsin and ADAM10 dependent proteolytic switches that can mediate Notch activation in response to force.

Identifiers

PMID39026694
PMCPMC11257581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.